Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Regenerative Medical Technology (RMTG) Income from Continuing Operations (2018 - 2025)

Historic Income from Continuing Operations for Regenerative Medical Technology (RMTG) over the last 8 years, with Q3 2025 value amounting to -$3.9 million.

  • Regenerative Medical Technology's Income from Continuing Operations fell 34436.35% to -$3.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.6 million, marking a year-over-year increase of 73.94%. This contributed to the annual value of -$5.6 million for FY2024, which is 2284.43% up from last year.
  • Latest data reveals that Regenerative Medical Technology reported Income from Continuing Operations of -$3.9 million as of Q3 2025, which was down 34436.35% from -$1.3 million recorded in Q2 2025.
  • Regenerative Medical Technology's 5-year Income from Continuing Operations high stood at -$74211.0 for Q1 2023, and its period low was -$9.9 million during Q3 2021.
  • Over the past 5 years, Regenerative Medical Technology's median Income from Continuing Operations value was -$1.5 million (recorded in 2022), while the average stood at -$1.9 million.
  • Its Income from Continuing Operations has fluctuated over the past 5 years, first soared by 9559.03% in 2023, then tumbled by 254047.38% in 2024.
  • Regenerative Medical Technology's Income from Continuing Operations (Quarter) stood at -$1.6 million in 2021, then tumbled by 57.39% to -$2.5 million in 2022, then rose by 28.04% to -$1.8 million in 2023, then soared by 63.86% to -$639071.0 in 2024, then crashed by 516.01% to -$3.9 million in 2025.
  • Its Income from Continuing Operations was -$3.9 million in Q3 2025, compared to -$1.3 million in Q2 2025 and -$758890.0 in Q1 2025.